You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dysthyroid Orbitopathy

Showing 1 - 25 of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

mDixon TSE MRI Sequence And Conventional MRI Sequences In

Completed
  • Dysthyroid Ophthalmopathies
    • Paris, Ile De France, France
      Fondation Ophtalmologique Adolphe de Rothschild
    May 26, 2021

    Customized Multiple Orbital Wall Decompression for

    Recruiting
    • Thyroid Eye Disease
    • Modified multiple orbital wall decompression
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital
    Nov 17, 2022

    Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)

    Recruiting
    • Graves Ophthalmopathy
    • Tocilizumab 20 Mg/mL Intravenous Solution
    • MethylPREDNISolone Injectable Solution
    • Milano, MI, Italy
    • +3 more
    Aug 3, 2022

    Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

    Not yet recruiting
    • Thyroid Eye Disease
    • VRDN-001 10 mg/kg Drug:
    • (no location specified)
    Sep 7, 2023

    Thyroid Eye Disease Trial in United States (VRDN-001, Placebo)

    Recruiting
    • Thyroid Eye Disease
    • Beverly Hills, California
    • +16 more
    Aug 11, 2022

    Graves Disease, Graves Ophthalmopathy, Liver Diseases Trial (every week IVMP therapy, very high doses IVMP therapy)

    Completed
    • Graves Disease
    • +13 more
    • every week IVMP therapy
    • very high doses IVMP therapy
    • (no location specified)
    Sep 11, 2018

    Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)

    Not yet recruiting
    • Thyroid-Associated Ophthalmopathy
    • (no location specified)
    Mar 18, 2022

    Graves Ophthalmopathy Trial in Sofia (Orbital radiotherapy)

    Completed
    • Graves Ophthalmopathy
    • Orbital radiotherapy
    • Sofia, Bulgaria
      University Hospital of Endocrinology
    Mar 7, 2023

    Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)

    Recruiting
    • Graves Ophthalmopathy
    • Hsinchu, Taiwan
    • +1 more
    Dec 1, 2022

    Graves Ophthalmopathy Trial in Pisa (Sirolimus)

    Not yet recruiting
    • Graves Ophthalmopathy
    • Pisa, Italy
      Ospedale Cisanello-Endocrinology II
    Nov 2, 2022

    Active Moderate to Severe Graves' Orbitopathy Trial (SHR-1314)

    Not yet recruiting
    • Active Moderate to Severe Graves' Orbitopathy
    • (no location specified)
    May 23, 2022

    Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)

    Completed
    • Thyroid Associated Orbitopathy
    • Cairo, Egypt
      Cairo University
    Jul 15, 2022

    Sirolimus in Graves' Orbitopathy

    Completed
    • Graves Ophthalmopathy
    • Pisa, PI, Italy
      Endocrinologia II
    Apr 19, 2022

    Clinical Activity of TAO Using Periocular Images Taken by

    Completed
    • Thyroid Eye Disease
    • taking periorbital selfie images using smartphones
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      Seoul National University Bundang Hospital
    Feb 15, 2023

    Graves Ophthalmopathy Trial in Sofia (Methylprednisolone)

    Completed
    • Graves Ophthalmopathy
    • Sofia, Bulgaria
      University Hospital of Endocrinology
    Mar 29, 2023

    Thyroid Associated Ophthalmopathy, Surgical Procedure, Unspecified Trial in Manresa (3D printing model/guide., Standard surgery)

    Recruiting
    • Thyroid Associated Ophthalmopathy
    • Surgical Procedure, Unspecified
    • 3D printing model/guide.
    • Standard surgery
    • Manresa, Barcelona, Spain
      Eduard Pedemonte Sarrias
    Mar 8, 2022

    Glucocorticoids and Bone in Graves' Ophthalmopathy

    Active, not recruiting
    • Graves Ophthalmopathy
    • Aarhus C, Central Denmark Region, Denmark
    • +1 more
    Feb 21, 2022

    Graves Orbitopathy Trial in Katowice (rabbit anti-thymocyte globulin)

    Recruiting
    • Graves Orbitopathy
    • rabbit anti-thymocyte globulin
    • Katowice, Silesia, Poland
      Department of Internal Medicine and Oncological Chemotherapy, Me
    Jan 14, 2022

    Immunological Follow-up of Patients With Basedow's Orbitopathy

    Completed
    • Graves Orbitopathy
      • Montpellier, France
        Uhmontpellier
      Jan 10, 2022

      Graves' Orbitopathy Trial in Pisa (Atorvastatin 20mg, Placebo)

      Not yet recruiting
      • Graves' Orbitopathy
      • Atorvastatin 20mg
      • Placebo
      • Pisa, Italy
        Ospedale Cisanello-Endocrinology II
      Sep 8, 2021

      Normal Tension Glaucoma, Primary Open-angle Glaucoma, Glaucoma, Suspect Trial in Seongnam-si, Seoul (Eybelis ophthalmic solution

      Recruiting
      • Normal Tension Glaucoma
      • +3 more
      • Eybelis ophthalmic solution 0.002%
      • Seongnam-si, Korea, Republic of
      • +7 more
      Mar 6, 2022

      Thyroid Associated Ophthalmopathy, Hypercholesterolemia Trial in Pisa (Atorvastatin, Methylprednisolone)

      Completed
      • Thyroid Associated Ophthalmopathy
      • Hypercholesterolemia
      • Pisa, Italy
        Ospedale Cisanello-Endocrinology I and II
      Aug 12, 2021

      Thyroid Eye Disease Trial in Germany, Italy, United States (Teprotumumab)

      Completed
      Has Results
      • Thyroid Eye Disease
      • Teprotumumab
      • Beverly Hills, California
      • +12 more
      Dec 9, 2021

      Thyroid Eye Disease, Graves' Orbitopathy Trial in Germany, Italy, United States (Teprotumumab, Placebo)

      Completed
      Has Results
      • Thyroid Eye Disease
      • Graves' Orbitopathy
      • Teprotumumab
      • Placebo
      • Beverly Hills, California
      • +13 more
      Jan 31, 2022

      Genetics and Epigenetics of Graves' Orbitopathy

      Completed
      • Graves Ophthalmopathy
      • No Intervention
      • Pisa, Italy
        Ospedale Cisanello-Endocrinology I and II
      Jul 22, 2020